Sanara Medtech Inc (SMTI)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $297.06M
Last updated: Nov 17, 2026 at 11:02 AM ET
Sanara Medtech Inc (SMTI) Stock Forecast
Analysts expect Sanara Medtech (SMTI) to earn $0.20 per share in the fiscal year ending Dec 31, 2026, on revenue of $116.60M. Of 3 analysts, 0 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 3 ratings average 3.00, inside the Hold band from 2.5 up to 3.5. All 3 rate it Hold.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 0 | 0.0% |
| Buy | 0 | 0.0% |
| Hold | 3 | 100.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Hold
- Total analysts
- 3
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 170.0% and revenue estimates rise 14.2%.
- Fiscal year ending Dec 31, 2026
- $0.20
- EPS consensus, revenue $116.60M
- Fiscal year ending Dec 31, 2027
- $0.54
- EPS consensus, revenue $133.19M
- Next report
- Mar 22, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.20 | $0.20 to $0.20 | 1 | $116.60M | $116.60M to $116.60M | 1 |
| Dec 31, 2027 | $0.54 | $0.54 to $0.54 | 1 | $133.19M | $132.00M to $134.39M | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.14 | $0.11 to $0.19 | 5 | $31.31M | $28.42M to $33.49M | 5 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 11.1% from $0.18.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $0.20 | $0.18 | $0.18 | $0.18 | $0.18 | +11.1% |
| Fiscal year ending Dec 31, 2027 | $0.54 | $0.54 | $0.54 | $0.54 | $0.54 | 0.0% |
Frequently Asked Questions About SMTI
What is the SMTI stock forecast?
Consensus analyst estimates put Sanara Medtech's EPS at $0.20 for the fiscal year ending Dec 31, 2026, on revenue of $116.60M. The consensus rating from 3 analysts is Hold.
How do analysts rate SMTI stock?
Of 3 analysts covering Sanara Medtech, 0 rate it Strong Buy, 0 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.
What EPS do analysts expect from SMTI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $0.20, with estimates from $0.20 to $0.20 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.54, with estimates from $0.54 to $0.54 from 1 analyst.
What revenue do analysts expect from Sanara Medtech next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $116.60M, with estimates from $116.60M to $116.60M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $133.19M, with estimates from $132.00M to $134.39M.
How many analysts cover SMTI?
3 analysts rate Sanara Medtech stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.
SMTI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors